Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21701037 | 1.00 | ALDH1A1 (0.58) | ALDH1A1LMNAHTTMAPTSLC6A3 | |
| Trifluoroacetic Acid SCHEMBL21700850 | 0.93 | ALDH1A1 (0.52) | ALDH1A1LMNAHTTMAPT | |
| SCHEMBL21700956 | 0.82 | ALDH1A1 (0.56) | ALDH1A1LMNAHTTMAPTNPC1 | |
| SCHEMBL30138089 | 0.78 | ALDH1A1 (0.54) | ALDH1A1LMNAHTTMAPTNPC1 | |
| SCHEMBL29697850 | 0.76 | ALDH1A1 (0.53) | ALDH1A1LMNAHTTMAPTNPC1 | |
| SCHEMBL21700899 | 0.72 | MC2R (0.56) | ALDH1A1LMNAKMT2A | |
| Tert-Butyl Formate SCHEMBL27751337 | 0.72 | ALDH1A1 (0.60) | ALDH1A1LMNAHTTMAPTNPC1 | |
| SCHEMBL853688 | 0.72 | ALDH1A1 (0.69) | ALDH1A1LMNAHTTMAPTKMT2A | |
| SCHEMBL26597101 | 0.72 | ALDH1A1 (0.52) | ALDH1A1LMNAHTTMAPTNPC1 | |
| SCHEMBL4159162 | 0.72 | ALDH1A1 (0.76) | ALDH1A1LMNAHTTMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3802500-A1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |